PubMed

Modeling biological rhythms in failure time data.

Elkum NB, Myles JD.

J Circadian Rhythms. 2006 Nov 7;4:14.PMID: 17090302 [PubMed]Related articlesFree article

Analyzing biological rhythms in clinical trials.

Elkum NB, Myles JD, Kumar P.

Contemp Clin Trials. 2008 Sep;29(5):720-6. Epub 2008 May 18.PMID: 18571991 [PubMed - indexed for MEDLINE]Related articles

Overview of resistance to systemic therapy in patients with breast cancer.

Gonzalez-Angulo AM, Morales-Vasquez F, Hortobagyi GN.

Adv Exp Med Biol. 2007;608:1-22. Review.PMID: 17993229 [PubMed - indexed for MEDLINE]Related articles

Randomized phase 3 trial of fluorouracil, epirubicin, and cyclophosphamide alone or followed by Paclitaxel for early breast cancer.

Martín M, Rodríguez-Lescure A, Ruiz A, Alba E, Calvo L, Ruiz-Borrego M, Munárriz B, Rodríguez CA, Crespo C, de Alava E, López García-Asenjo JA, Guitián MD, Almenar S, González-Palacios JF, Vera F, Palacios J, Ramos M, Gracia Marco JM, Lluch A, Alvarez I, Seguí MA, Mayordomo JI, Antón A, Baena JM, Plazaola A, Modolell A, Pelegrí A, Mel JR, Aranda E, Adrover E, Alvarez JV, García Puche JL, Sánchez-Rovira P, Gonzalez S, López-Vega JM; GEICAM 9906 Study Investigators.

J Natl Cancer Inst. 2008 Jun 4;100(11):805-14. Epub 2008 May 27.PMID: 18505968 [PubMed - indexed for MEDLINE]Related articlesFree article

Estimation of age- and stage-specific Catalan breast cancer survival functions using US and Catalan survival data.

Vilaprinyo E, Rué M, Marcos-Gragera R, Martínez-Alonso M.

BMC Cancer. 2009 Mar 30;9:98.PMID: 19331670 [PubMed - indexed for MEDLINE]Related articlesFree article

Ethical and methodological standards for laboratory and medical biological rhythm research.

Portaluppi F, Touitou Y, Smolensky MH.

Chronobiol Int. 2008 Nov;25(6):999-1016.PMID: 19005901 [PubMed - indexed for MEDLINE]Related articles

A semiparametric model for regression analysis of interval-censored failure time data.

Finkelstein DM, Wolfe RA.

Biometrics. 1985 Dec;41(4):933-45.PMID: 3830259 [PubMed - indexed for MEDLINE]Related articles

A proportional hazards model for interval-censored failure time data.

Finkelstein DM.

Biometrics. 1986 Dec;42(4):845-54.PMID: 3814726 [PubMed - indexed for MEDLINE]Related articles

Circadian rhythms, sleep, and the menstrual cycle.

Baker FC, Driver HS.

Sleep Med. 2007 Sep;8(6):613-22. Epub 2007 Mar 26. Review.PMID: 17383933 [PubMed - indexed for MEDLINE]Related articles

p27(Kip1) and cyclin E expression and breast cancer survival after treatment with adjuvant chemotherapy.

Porter PL, Barlow WE, Yeh IT, Lin MG, Yuan XP, Donato E, Sledge GW, Shapiro CL, Ingle JN, Haskell CM, Albain KS, Roberts JM, Livingston RB, Hayes DF.

J Natl Cancer Inst. 2006 Dec 6;98(23):1723-31.PMID: 17148774 [PubMed - indexed for MEDLINE]Related articlesFree article

WITHDRAWN: Multi-agent chemotherapy for early breast cancer.

Clarke MJ.

Cochrane Database Syst Rev. 2008 Oct 8;(4):CD000487. Review.PMID: 18843612 [PubMed - indexed for MEDLINE]Related articles

The proportional odds model for multivariate interval-censored failure time data.

Chen MH, Tong X, Sun J.

Stat Med. 2007 Dec 10;26(28):5147-61.PMID: 17476643 [PubMed - indexed for MEDLINE]Related articles

Extended adjuvant therapy with anastrozole among postmenopausal breast cancer patients: results from the randomized Austrian Breast and Colorectal Cancer Study Group Trial 6a.

Jakesz R, Greil R, Gnant M, Schmid M, Kwasny W, Kubista E, Mlineritsch B, Tausch C, Stierer M, Hofbauer F, Renner K, Dadak C, Rücklinger E, Samonigg H; Austrian Breast and Colorectal Cancer Study Group.

J Natl Cancer Inst. 2007 Dec 19;99(24):1845-53. Epub 2007 Dec 11. Erratum in: J Natl Cancer Inst. 2008 Feb 6;100(3):226. PMID: 18073378 [PubMed - indexed for MEDLINE]Related articlesFree article

[Clinical characteristics and prognostic factors of female breast cancer patients with 10 or more positive lymph nodes: a report of 128 patients]

Guan Y, Xu BH, Li Q, Zhang P, Zhao LM, Yuan P, Wang JY.

Zhonghua Yi Xue Za Zhi. 2008 Jan 8;88(2):77-81. Chinese. PMID: 18353207 [PubMed - indexed for MEDLINE]Related articles

WITHDRAWN: Tamoxifen for early breast cancer.

Clarke MJ.

Cochrane Database Syst Rev. 2008 Oct 8;(4):CD000486. Review.PMID: 18843611 [PubMed - indexed for MEDLINE]Related articles

Twenty-year follow-up of the Royal Marsden randomized, double-blinded tamoxifen breast cancer prevention trial.

Powles TJ, Ashley S, Tidy A, Smith IE, Dowsett M.

J Natl Cancer Inst. 2007 Feb 21;99(4):283-90.PMID: 17312305 [PubMed - indexed for MEDLINE]Related articlesFree article

Timing of breast cancer surgery in relation to menstrual cycle phase: no effect on 3-year prognosis: the ITS Study.

Thorpe H, Brown SR, Sainsbury JR, Perren TJ, Hiley V, Dowsett M, Nejim A, Brown JM.

Br J Cancer. 2008 Jan 15;98(1):39-44. Epub 2007 Dec 18.PMID: 18087287 [PubMed - indexed for MEDLINE]Related articlesFree article

Survival and breast relapse in 3834 patients with T1-T2 breast cancer after conserving surgery and adjuvant treatment.

Livi L, Paiar F, Saieva C, Scoccianti S, Dicosmo D, Borghesi S, Agresti B, Nosi F, Orzalesi L, Santini R, Barca R, Biti GP.

Radiother Oncol. 2007 Mar;82(3):287-93. Epub 2006 Dec 22.PMID: 17188382 [PubMed - indexed for MEDLINE]Related articles

Outcome prediction for estrogen receptor-positive breast cancer based on postneoadjuvant endocrine therapy tumor characteristics.

Ellis MJ, Tao Y, Luo J, A'Hern R, Evans DB, Bhatnagar AS, Chaudri Ross HA, von Kameke A, Miller WR, Smith I, Eiermann W, Dowsett M.

J Natl Cancer Inst. 2008 Oct 1;100(19):1380-8. Epub 2008 Sep 23.PMID: 18812550 [PubMed - indexed for MEDLINE]Related articlesFree article

Telomere DNA content predicts breast cancer-free survival interval.

Heaphy CM, Baumgartner KB, Bisoffi M, Baumgartner RN, Griffith JK.

Clin Cancer Res. 2007 Dec 1;13(23):7037-43.PMID: 18056180 [PubMed - indexed for MEDLINE]Related articlesFree article